España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
SAB Biotherapeutics
SABS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.67
0.29
8.58%
At close: -
$3.54
-0.13
-3.54%
After Hours: 9:27 AM EDT
Get Report
Comment
SAB Biotherapeutics (SABS) Forecast
News
Earnings
SAB Biotherapeutics (SABS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for SAB Biotherapeutics (NASDAQ:SABS) Stock
SAB Biotherapeutics Stock (NASDAQ: SABS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 07, 2024
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk
Wednesday, November 06, 2024
SAB BIO Says Co Completed Phase 1 Enrollment ...
Benzinga Newsdesk
SAB BIO Q3 2024 Cash, Cash Equivalents Availa...
Benzinga Newsdesk
Friday, October 18, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, October 09, 2024
Craig-Hallum Initiates Coverage On SAB Biothe...
Benzinga Newsdesk
Thursday, September 12, 2024
Oppenheimer Reiterates Outperform on SAB Biot...
Benzinga Newsdesk
Monday, September 09, 2024
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk
Wednesday, August 28, 2024
SAB Biotherapeutics shares are trading higher...
Benzinga Newsdesk
Oppenheimer Initiates Coverage On SAB Biother...
Benzinga Newsdesk
Monday, August 12, 2024
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk
Friday, August 09, 2024
SAB Biotherapeutics shares are trading lower ...
Benzinga Newsdesk
Thursday, August 08, 2024
SAB Biotherapeutics Q2 2024 GAAP EPS $(0.79) ...
Benzinga Newsdesk
Thursday, June 20, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
SAB Biotherapeutics Rebrands as SAB BIO, Focu...
Benzinga Newsdesk
Wednesday, June 19, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, June 18, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, June 07, 2024
Brookline Capital Initiates Coverage On SAB B...
Benzinga Newsdesk
Thursday, May 30, 2024
SAB Biotherapeutics Says CFO Michael King Wil...
Benzinga Newsdesk
Thursday, May 23, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, May 21, 2024
SAB Biotherapeutics shares are trading lower....
Benzinga Newsdesk
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk
SAB Biotherapeutics Announces FDA Has Provide...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk
Monday, May 20, 2024
SAB Biotherapeutics Q1 2024 GAAP EPS $(0.43) ...
Benzinga Newsdesk
Tuesday, April 16, 2024
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk
SAB Biotherapeutics' Has Completed Dosing The...
Benzinga Newsdesk
Tuesday, April 02, 2024
Chardan Capital Maintains Buy on SAB Biothera...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on SAB Biot...
Benzinga Newsdesk
Monday, March 25, 2024
SAB Biotherapeutics Announces Clinical Partne...
Benzinga Newsdesk
Friday, February 02, 2024
SAB Biotherapeutics Says Executive Chairman S...
Benzinga Newsdesk
Tuesday, January 23, 2024
SAB Biotherapeutics Receives Notice About Reg...
Benzinga Newsdesk
Monday, January 08, 2024
HC Wainwright & Co. Reiterates Buy on SAB Bio...
Benzinga Newsdesk
Friday, January 05, 2024
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Wednesday, January 03, 2024
Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
Tuesday, January 02, 2024
SAB Biotherapeutics Announces 1-for-10 Revers...
Benzinga Newsdesk
Monday, December 04, 2023
Biotechnology Value Fund, Reported A 5.3% Sta...
Charles Gross
Friday, December 01, 2023
VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
Wednesday, November 29, 2023
EXCLUSIVE: SAB Biotherapeutics Kickstarts Phase 1 Study For Its Lead Type 1 Diabetes Hopeful In Australia
Vandana Singh
EXCLUSIVE: SAB Biotherapeutics Tells Benzinga...
Benzinga Newsdesk
EXCLUSIVE: SAB Biotherapeutics Tells Benzinga...
Benzinga Newsdesk
EXCLUSIVE: SAB Biotherapeutics Tells Benzinga...
Benzinga Newsdesk
Thursday, November 16, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, November 14, 2023
HC Wainwright & Co. Maintains Buy on SAB Biot...
Benzinga Newsdesk
SAB Biotherapeutics Q3 EPS $(0.10) Beats $(0....
Benzinga Newsdesk
Tuesday, October 24, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
SAB Biotherapeutics Appoints Michael G. King ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
